Agios Pharmaceuticals (AGIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -412,781 | -304,742 | -201,309 | -89,289 | 673,725 |
| Depreciation Amortization | -2,018 | -1,531 | -1,231 | -70 | -8,833 |
| Accounts receivable | -6,468 | -920 | -877 | 765 | -1,299 |
| Accounts payable and accrued liabilities | 1,746 | 2,891 | 1,084 | -2,821 | 6,601 |
| Other Working Capital | -33,042 | -28,452 | -28,221 | -36,505 | -19,768 |
| Other Operating Activity | 79,586 | 55,990 | 41,941 | 16,431 | -1,040,267 |
| Operating Cash Flow | $-372,977 | $-276,764 | $-188,613 | $-111,489 | $-389,841 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,316 | -3,196 | -1,641 | -766 | -1,645 |
| Purchase Of Investment | -641,759 | -480,681 | -305,700 | -174,903 | -1,542,433 |
| Sale Of Investment | 1,033,259 | 780,985 | 508,894 | 288,256 | 1,018,383 |
| Other Investing Activity | -10,000 | -10,000 | -10,000 | 0 | 889,136 |
| Investing Cash Flow | $377,184 | $287,108 | $191,553 | $112,587 | $363,441 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8,676 | 6,119 | 1,684 | 1,619 | 14,442 |
| Financing Cash Flow | $8,676 | $6,119 | $1,684 | $1,619 | $14,442 |
| Beginning Cash Position | 76,247 | 76,247 | 76,247 | 76,247 | 88,205 |
| End Cash Position | 89,130 | 92,710 | 80,871 | 78,964 | 76,247 |
| Net Cash Flow | $12,883 | $16,463 | $4,624 | $2,717 | $-11,958 |
| Free Cash Flow | |||||
| Operating Cash Flow | -372,977 | -276,764 | -188,613 | -111,489 | -389,841 |
| Capital Expenditure | -4,316 | -3,196 | -1,641 | -766 | -1,685 |
| Free Cash Flow | -377,293 | -279,960 | -190,254 | -112,255 | -391,526 |